{"id":173674,"title":"ARCHIVED - Regulatory Issues Associated with the Development and Licensing of SARS Vaccines and Immunotherapy Products - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T16:02:28.346000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/activities/regulatory-issues-associated-development-licensing-sars-vaccines-immunotherapy-products.html","snippet":"ARCHIVED - Regulatory Issues Associated with the Development and Licensing of SARS Vaccines and Immunotherapy Products - Canada.ca Skip to main content Skip to \"About government\" Skip to section menu Language selection Français fr / Gouvernement du Canada Search Search Canada.ca…","rawSnapshotUrl":"/api/snapshots/raw/173674","browseUrl":"https://replay.healtharchive.ca/job-1/20250418160228/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/activities/regulatory-issues-associated-development-licensing-sars-vaccines-immunotherapy-products.html#ha_snapshot=173674","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}